Home /Research /MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma
OTHER

MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma

De-Liang Ma, Katharine A. Price, Eric J. Moore, Samir H. Patel, M.L. Hinni, Briant Fruth, Nathan R. Foster, K. Van Abel, Linda X. Yin, M.A. Neben-Wittich, L.A. McGee, J.C. Rwigema, David M. Routman, Scott C. Lester, Daniel L. Price, Jeffrey R. Janus, Jan L. Kasperbauer, Thomas H. Nagel, Ashish V. Chintakuntlawar, P. Savvides

Year
2021
Citations
53

Keywords

MedicineAdjuvantHuman papillomavirusOncologyAdjuvant radiotherapyBasal cellInternal medicineRadiation therapyAdjuvant therapyCancer

Related papers

Browse all OTHER papers